glp semaglutide Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity Hims Inc. - Hims &

Conclusions Using GLP-1RAs versus insulin for type 2 diabetes patients requiring intensified injection therapy in clinical practice is cost-effective.

Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin

But in psychiatry, these arent just weight-loss drugs

Eli Lilly (NYSE:LLY) reported Phase 3 results for obesity drugs retatrutide and Foundayo at the American Diabetes Association 86th Scientific Sessions in 2026

PlexusDx provides expert guidance on storage conditions, expiration timelines, and how to protect your investment in your weight loss journey

Stephanie Widmer explains the difference between gelatin and GLP-1s and debunks the viral "nature's Ozempic" trend taking over social media.